ArticleOncology reports2023

TRIP13 overexpression promotes gefitinib resistance in non‑small cell lung cancer via regulating autophagy and phosphorylation of the EGFR signaling pathway.

Zhangxian Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.